v3.19.3

Note 5 - Other Balance Sheet Information

6 Months Ended

Jun. 30, 2019

Notes to Financial Statements

Supplemental Balance Sheet Disclosures [Text Block]

Note

5.

 Other Balance Sheet Information

Prepaid and other current assets consist of the following (in thousands):

		June 30,				December 31,
		2019				2018
Prepaid clinical trial expenses		$	435			$	5
Equity issuance costs			343				-
Prepaid insurance			670				-
Other prepaid expenses			174				5
Total prepaid and other current assets		$	1,622			$	10

Accrued liabilities consist of the following (in thousands):

		June 30,				December 31,
		2019				2018
Payroll and related expenses		$	508			$	241
Accrued term loan final payment			569				421
Accrued clinical trial expense			8				-
Professional fees and other costs			395				195
Total accrued liabilities		$	1,480			$	857

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureTextBlockAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-URI http://asc.fasb.org/topic&trid=2122208

+ Details

Name:	us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration